Soligenix, Inc. Gains 271%
Tue, Jul 09, 2024 at 07:19 PM
Soligenix, Inc. (SNGX:NASDAQ) shot up at $7.42, representing a gain of 271%. On Tue, Jul 09, 2024, SNGX:NASDAQ hit a New 2-Week High of $7.42. The stock appeared on our News Catalysts scanner on Tue, Jul 09, 2024 at 06:37 PM in the 'INVESTOR UPDATE' category. From Tue, Jun 25, 2024, the stock recorded 22.22% Up Days and 20.00% Green Days
The stock spiked on Tue, Jul 09, 2024 at $14.83 with a volume of 132M+.
About Soligenix, Inc. (SNGX:NASDAQ)
Soligenix Inc is a clinical stage biopharmaceutical company focused on focused on developing and commercializing products to treat rare diseases where there is an unmet medical need.
Top 10 Gainers:
- Soligenix, Inc. (SNGX:NASDAQ), 271%
- Zapp Electric Vehicles Group Limited (ZAPP:NASDAQ), 94.26%
- Pineapple Holdings Inc Com (PEGY:NASDAQ), 91.67%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 84.18%
- uniQure N.V. (QURE:NASDAQ), 76.46%
- Naas Technology Inc. (NAAS:NASDAQ), 68.39%
- Bite Acquisition Corp. (BITE:NYSEMKT), 43.68%
- Bite Acquisition Corp. (BITE:NYSE), 43.68%
- Shineco Inc. (SISI:NASDAQ), 43.17%
- Longeveron Inc. (LGVN:NASDAQ), 38.65%